PMV Pharmaceuticals GAAP EPS of -$0.34 beats by $0.05
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
EU to study potential vaccine for Lyme disease: companies
Can cause rashes and flu-like symptoms among people who are bitten
The Office’s Lucy Davis ‘overwhelmed’ by kindness after cancer diagnosis
The Office actress Lucy Davis has thanked fans for their "kindness and support" after revealing she has incurable breast cancer.
One of the most common brain disorders is one of the most misunderstood – how functional neurological disorder is both ‘all in your head’ and beyond it
Millions of people suffer from debilitating symptoms their doctors don’t quite believe. But advances in neuroscience and education may be changing the tides for treatment.
How pet sterilisation creates healthier futures
A Mandela Day veterinary outreach initiative provided sterilisation and essential treatment to 42 animals, highlighting the importance of accessible veterinary care.
We asked, you answered: Labiotech’s 2026 reader survey results
Labiotech's reader survey reveals what our audience wants, needs, and is interested in for 2026. The post We asked, you answered: Labiotech’s 2026 reader survey results appeared first on Labiotech.eu…
Inquiry into Alberta teen's overdose death calls for urgent introduction of involuntary care
The overdose of a 15-year-old boy in Edmonton underscores the urgent need to bring involuntary addiction care into force for Alberta’s youth, says the judge who led a fatality inquiry into his death.